Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial in Post ERCP Pancreatitis

NCT01946984 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

182

Enrollment

OTHER

Sponsor class

Conditions

Post-ERCP Acute Pancreatitis.

Interventions

PROCEDURE: ERCP
DRUG: Diclofenac hydroxyethylpyrrolidine
DRUG: Normal Saline

Sponsor

Specialized Arab Hospital